Article Versions Notes

Mongkolsucharitkul P, Surawit A, Pumeiam S, Sookrung N, Tungtrongchitr A, Phisalprapa P, Sayabovorn N, Srivanichakorn W, Washirasaksiri C, Auesomwang C, et al. SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand. Vaccines. 2022; 10(7):1131. https://doi.org/10.3390/vaccines10071131

Mongkolsucharitkul, Pichanun, Apinya Surawit, Sureeporn Pumeiam, Nitat Sookrung, Anchalee Tungtrongchitr, Pochamana Phisalprapa, Naruemit Sayabovorn, Weerachai Srivanichakorn, Chaiwat Washirasaksiri, Chonticha Auesomwang, and et al. 2022. "SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand" Vaccines 10, no. 7: 1131. https://doi.org/10.3390/vaccines10071131

Mongkolsucharitkul, P., Surawit, A., Pumeiam, S., Sookrung, N., Tungtrongchitr, A., Phisalprapa, P., Sayabovorn, N., Srivanichakorn, W., Washirasaksiri, C., Auesomwang, C., Sitasuwan, T., Chaisathaphol, T., Tinmanee, R., Chayakulkeeree, M., Phoompoung, P., Tangjittipokin, W., Senawong, S., Sanpawitayakul, G., Muangman, S., ... on behalf of the Siriraj Population Health and Nutrition Research (SPHERE) Group. (2022). SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand. Vaccines, 10(7), 1131. https://doi.org/10.3390/vaccines10071131